title: Patients with acute skin loss: are they best managed on a burns unit?
abstract: Patients who are critically ill and have large areas of skin loss or breakdown present a difficult management problem. They require the combination of intensive therapy facilities to support failing organs and specialized skin care, sometimes including extensive debridement and reconstruction. The expertise required for both aspects of treatment are found uniquely on a burns unit. We present five patients with large areas of cutaneous loss or damage secondary to a variety of non-burn aetiologies who were managed on a burns unit. We suggest that a burns unit may be the most appropriate place for such patients to be treated during both the acute phase of their illness and the later stages of surgical reconstruction and physical rehabilitation.
authors.affiliation: Burn Unit, Chelsea and Westminster Hospital, London, UK. shehan_h@hotmail.com
authors.forename: S
authors.initials: S
authors.lastname: Hettiaratchy
authors.forename: D
authors.initials: D
authors.lastname: Moloney
authors.forename: J
authors.initials: J
authors.lastname: Clarke
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects; D002053:Burn Units; D003422:Critical Care / Q000379:methods*; D003875:Drug Eruptions / Q000628:therapy; D019115:Fasciitis, Necrotizing / Q000628:therapy; D005260:Female; D006801:Humans; D008131:London; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D008875:Middle Aged; D009336:Necrosis; D018805:Sepsis / Q000628:therapy; D012871:Skin Diseases / Q000628:therapy*; D013262:Stevens-Johnson Syndrome / Q000628:therapy
chemical_list: D000964:Antimetabolites, Antineoplastic; D008727:Methotrexate